Exploring why medication management apps often fail to meet the complex needs of Parkinson's patients and the innovative solutions bridging this gap.
Discover how Casirivimab/Imdevimab, a COVID-19 treatment, unexpectedly improved axial symptoms in Parkinson's disease patients.